Do dose-volume metrics predict pulmonary function changes in lung irradiation?

International Journal of Radiation Oncology Biology Physics

Volumn 55, Issue 4, 2003, Pages 921-929

  Allen, Aaron M ^a,b   Henning, G T ^a   Ten Haken, R K ^a   Hayman, J A ^a   Martel, M K ^a  

^a UNIVERSITY OF MICHIGAN   (United States)

^b UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

Author keywords

DVH; MLD; NSCLC; PFTs; V20

Indexed keywords

BIOLOGICAL ORGANS; CHEMOTHERAPY; CORRELATION METHODS; DOSIMETRY; REGRESSION ANALYSIS; TUMORS;

DOSE-VOLUME METRICES;

RADIATION EFFECTS;

CISPLATIN; NAVELBINE;

ADULT; AGED; ARTICLE; ATELECTASIS; CANCER COMBINATION CHEMOTHERAPY; CANCER RADIOTHERAPY; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORRELATION ANALYSIS; DOSIMETRY; FEMALE; HUMAN; LINEAR REGRESSION ANALYSIS; LUNG FUNCTION; LUNG FUNCTION TEST; LUNG NON SMALL CELL CANCER; LUNG VOLUME; MAJOR CLINICAL STUDY; MALE; MODEL; PHASE 1 CLINICAL TRIAL; PNEUMONIA; PREDICTION; PRIORITY JOURNAL; RADIATION DOSE; RADIOMETRY; RISK ASSESSMENT;

EID: 0037443506     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0360-3016(02)04288-8     Document Type: Article

References (37)

1. Marks L.B. The pulmonary effects of thoracic irradiation. Oncology (Huntingt). 8:1994;89-106.
2. Graham M.V., Purdy J.A., Emami B., et al. Clinical dose-volume histogram analysis for pneumonitis after 3D treatment for non-small cell lung cancer (NSCLC). Int J Radiat Oncol Biol Phys. 45:1999;323-329.
3. Martel M.K., Ten Haken R.K., Hazuka M.B., et al. Dose-volume histogram and 3D treatment planning evaluation of patients with pneumonitis. Int J Radiat Oncol Biol Phys. 28:1994;575-581.
4. Kwa S.L., Lebesque J.V., Theuws J.C., et al. Radiation pneumonitis as a function of mean lung dose An analysis of pooled data of 540 patients. Int J Radiat Oncol Biol Phys. 42:1998;1-9.
5. Oetzel D., Schraube P., Hensley F., et al. Estimation of pneumonitis risk in three-dimensional treatment planning using dose-volume histogram analysis. Int J Radiat Oncol Biol Phys. 33:1995;455-460.
6. Anscher M.S., Kong F.M., Andrews K., et al. Plasma transforming growth factor beta1 as a predictor of radiation pneumonitis. Int J Radiat Oncol Biol Phys. 41:1998;1029-1035.
7. Garipagaoglu M., Munley M.T., Hollis D., et al. The effect of patient-specific factors on radiation-induced regional lung injury. Int J Radiat Oncol Biol Phys. 45:1999;331-338.
8. Theuws J.C., Muller S.H., Seppenwoolde Y., et al. Effect of radiotherapy and chemotherapy on pulmonary function after treatment for breast cancer and lymphoma A follow-up study. J Clin Oncol. 17:1999;3091-3100.
9. Marks L.B., Munley M.T., Bentel G.C., et al. Physical and biological predictors of changes in whole-lung function following thoracic irradiation. Int J Radiat Oncol Biol Phys. 39:1997;563-570.
10. Boersma L.J., Damen E.M., de Boer R.W., et al. Estimation of overall pulmonary function after irradiation using dose-effect relations for local functional injury. Radiother Oncol. 36:1995;15-23.
11. Choi N.C., Kanarek D.J., Grillo H.C. Effect of postoperative radiotherapy on changes in pulmonary function in patients with stage II and IIIA lung carcinoma. Int J Radiat Oncol Biol Phys. 18:1990;95-99.
12. Curran W.J., Moldofsky P.J., Solin L.J. Observations on the predictive value of perfusion lung scans on post-irradiation pulmonary function among 210 patients with bronchogenic carcinoma. Int J Radiat Oncol Biol Phys. 24:1992;31-36.
13. Rubenstein J.H., Richter M.P., Moldofsky P.J., et al. Prospective prediction of post-radiation therapy lung function using quantitative lung scans and pulmonary function testing. Int J Radiat Oncol Biol Phys. 15:1988;83-87.
14. Fan M., Marks L.B., Hollis D., et al. Can we predict radiation-induced changes in pulmonary function based on the sum of predicted regional dysfunction? J Clin Oncol. 19:2001;543-550.
15. Fan M., Marks L.B., Lind P., et al. Relating radiation-induced regional lung injury to changes in pulmonary function tests. Int J Radiat Oncol Biol Phys. 51:2001;311-317.
16. Seppenwoolde Y., Muller S.H., Theuws J.C., et al. Radiation dose-effect relations and local recovery in perfusion for patients with non-small-cell lung cancer. Int J Radiat Oncol Biol Phys. 47:2000;681-690.
17. Boersma L.J., Damen E.M., de Boer R.W., et al. Recovery of overall and local lung function loss 18 months after irradiation for malignant lymphoma. J Clin Oncol. 14:1996;1431-1441.
18. Boersma L.J., Damen E.M., de Boer R.W., et al. Dose-effect relations for local functional and structural changes of the lung after irradiation for malignant lymphoma. Radiother Oncol. 32:1994;201-209.
19. Marks L.B. Physiology-based studies of radiation-induced normal tissue injury. Radiother Oncol. 51:1999;101-103.
20. Curran W.J. Jr, Moldofsky P.J., Solin L.J. Analysis of the influence of elective nodal irradiation on postirradiation pulmonary function. Cancer. 65:1990;2488-2493.
21. Kwa S.L., Theuws J.C., Wagenaar A., et al. Evaluation of two dose-volume histogram reduction models for the prediction of radiation pneumonitis. Radiother Oncol. 48:1998;61-69.
22. Hayman J.A., Martel M.K., Ten Haken R.K., et al. Dose escalation in non-small-cell lung cancer using three-dimensional conformal radiation therapy Update of a phase I trial. J Clin Oncol. 19:2001;127-136.
23. Robertson J.M., Ten Haken R.K., Hazuka M.B., et al. Dose escalation for non-small cell lung cancer using conformal radiation therapy. Int J Radiat Oncol Biol Phys. 37:1997;1079-1085.
24. Kutcher G.J., Burman C., Brewster L., et al. Histogram reduction method for calculating complication probabilities for three-dimensional treatment planning evaluations. Int J Radiat Oncol Biol Phys. 21:1991;137-146.
25. Burman C., Kutcher G.J., Emami B., et al. Fitting of normal tissue tolerance data to an analytic function. Int J Radiat Oncol Biol Phys. 21:1991;123-135.
26. Lyman J.T. Complication probability as assessed from dose-volume histograms. Radiat Res Suppl. 8:1985;S13-S19.
27. Lyman J.T., Wolbarst A.B. Optimization of radiation therapy, III A method of assessing complication probabilities from dose-volume histograms. Int J Radiat Oncol Biol Phys. 13:1987;103-109.
28. Lee J.S., Scott C., Komaki R., et al. Concurrent chemoradiation therapy with oral etoposide and cisplatin for locally advanced inoperable non-small-cell lung cancer Radiation Therapy Oncology Group protocol 91-06. J Clin Oncol. 14:1996;1055-1064.
29. Choy H., Akerley W., Safran H., et al. Multiinstitutional phase II trial of paclitaxel, carboplatin, and concurrent radiation therapy for locally advanced non-small-cell lung cancer. J Clin Oncol. 16:1998;3316-3322.
30. Curran W, Scott C, Langer C, et al. Phase III comparison of sequential vs. concurrent chemoradiation for Pts. with unresected stage III non-small cell lung cancer (NSCLC): Initial report of Radiation Therapy Oncology Group (RTOG) 94-10. Proceedings of the American Society of Clinical Oncology (ASCO), New Orleans, LA [Abstract]. J Clin Oncol 2000;484a.
31. Gauden S.J., Tripcony L. The curative treatment by radiation therapy alone of stage I non-small cell lung cancer in a geriatric population. Lung Cancer. 32:2001;71-79.
32. Zierhut D., Bettscheider C., Schubert K., et al. Radiation therapy of stage I and II non-small cell lung cancer (NSCLC). Lung Cancer. 34:(Suppl. 3):2001;S39-S43.
33. Mehta M., Scrimger R., Mackie R., et al. A new approach to dose escalation in non-small-cell lung cancer. Int J Radiat Oncol Biol Phys. 49:2001;23-33.
34. Martel M.K., Ten Haken R.K., Hazuka M.B., et al. Estimation of tumor control probability model parameters from 3-D dose distributions of non-small cell lung cancer patients. Lung Cancer. 24:1999;31-37.
35. Fu X.L., Huang H., Bentel G., et al. Predicting the risk of symptomatic radiation-induced lung injury using both the physical and biologic parameters V(30) and transforming growth factor beta. Int J Radiat Oncol Biol Phys. 50:2001;899-908.
36. Anscher M.S., Marks L.B., Shafman T.D., et al. Using plasma transforming growth factor beta-1 during radiotherapy to select patients for dose escalation. J Clin Oncol. 19:2001;3758-3765.
37. Travis E.L., Liao Z.X., Tucker S.L. Spatial heterogeneity of the volume effect for radiation pneumonitis in mouse lung. Int J Radiat Oncol Biol Phys. 38:1997;1045-1054.